Influvac Junior

Pajjiż: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Influenza virus A/California/7/2009 (H1N1) - like strain 7.5ug (A/California/7/2009 NYMC X-181); Influenza virus A/Hong Kong/4801/2014 (H3N2) - like strain 7.5ug (A/New Caledonia/71/2014, X-257A); Influenza virus B/Brisbane/60/2008 - like strain 7.5ug (B/Brisbane/60/2008, wild type)

Disponibbli minn:

Viatris Limited

INN (Isem Internazzjonali):

Influenza virus A/California/7/2009 (H1N1) - like strain 7.5 µg (A/California/7/2009 NYMC X-181)

Dożaġġ:

0.25 mL

Għamla farmaċewtika:

Suspension for injection

Kompożizzjoni:

Active: Influenza virus A/California/7/2009 (H1N1) - like strain 7.5ug (A/California/7/2009 NYMC X-181) Influenza virus A/Hong Kong/4801/2014 (H3N2) - like strain 7.5ug (A/New Caledonia/71/2014, X-257A) Influenza virus B/Brisbane/60/2008 - like strain 7.5ug (B/Brisbane/60/2008, wild type) Excipient: Calcium chloride dihydrate Dibasic sodium phosphate dihydrate Magnesium chloride hexahydrate Monobasic potassium phosphate Potassium chloride Sodium chloride Water for injection

Unitajiet fil-pakkett:

Syringe, glass, Type 1, clear with FM457 bromobutyl rubber stopper, 1 dose unit

Klassi:

Prescription

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

Abbott Biologicals BV

Indikazzjonijiet terapewtiċi:

For the prevention of influenza caused by the influenza virus, types A and B in children aged 6 months to 35 months.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Syringe, glass, Type 1, clear with FM457 bromobutyl rubber stopper - 1 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light - Syringe, glass, Type 1, clear with FM457 bromobutyl rubber stopper - 10 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light

Data ta 'l-awtorizzazzjoni:

2012-01-04